Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

Di-PKD: A Pilot Trial of Dietary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease

Study ID: NCT06786260
Start Date: 2025-12
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Interventional Diet

Sponsor

Loma Linda University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Learn More About Tukysa Once it is Out in the Korean Market

Study ID: NCT06873191
Start Date: 2026-12-01
End Date: 2030-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment
Sponsor

Pfizer

Source: clinicaltrials.gov

Share:
Add to list

Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study

Study ID: NCT07123649
Start Date: 2026-02
End Date: 2029-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

364

Intervention / Treatment

Shared Decision-Making Toolkit

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Low-Count Quantitative SPECT for Men Treated With Radium-223

Study ID: NCT07221825
Start Date: 2025-11-30
End Date: 2027-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

38

Intervention / Treatment

Low-count quantitative single-photon emission computed tomography imaging

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Intervention for Communication Quality of Life in Primary Progressive Aphasia

Study ID: NCT07219680
Start Date: 2026-01-03
End Date: 2027-08
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Multicomponent Lexical Retrieval Training

Multicomponent Video Implemented Script Training in Aphasia

Sponsor

University of Texas at Austin

Source: clinicaltrials.gov

Share:
Add to list

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Study ID: NCT07020533
Start Date: 2026-05-08
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

46

Intervention / Treatment

Biospecimen Collection

Electronic Health Record Review

Haploidentical Hematopoietic Cell Transplantation

Letermovir

Multi-peptide CMV-Modified Vaccinia Ankara Vaccine

Myeloablative Conditioning

Pheresis

Recombinant Granulocyte Colony-Stimulating Factor

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Internet Delivered Therapy for Social Anxiety in Adults

Study ID: NCT06767878
Start Date: 2026-01
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

62

Intervention / Treatment

PORTiSOFIE

Sponsor

Lusófona Group

Source: clinicaltrials.gov

Share:
Add to list

Treatment of Depression Post-SCI

Study ID: NCT04263285
Start Date: 2026-02
End Date: 2029-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

14

Intervention / Treatment

rTMS

Sponsor

Medical University of South Carolina

Source: clinicaltrials.gov

Share:
Add to list

N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer

Study ID: NCT07217496
Start Date: 2025-11-30
End Date: 2027-05-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

Nogapendekin Alfa Inbakicept (N803)

Veterinary Nursing (EV)

Pembrolizumab

Research Biospecimen Collection

Radiographic Imaging

Tumor Biopsy

Sponsor

Vadim S Koshkin

Source: clinicaltrials.gov

Share:
Add to list

ACE-D: Accelerating Cognition-guided Signatures to Enhance Translation in Depression: Clinical Trial

Study ID: NCT06408246
Start Date: 2026-02-01
End Date: 2029-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

160

Intervention / Treatment

Guanfacine

Sertraline

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list